Glycosylated hemoglobin is a predictive factor for response of radical radiotherapy in patients with stage 3 non-small cell lung cancer
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0006199
- Lead Sponsor
- Kyung Hee University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Histologically confirmed primary lung cancer
- From January 2010 to December 2019, the patients received radical radiotherapy in Kyung University Medical Center for management of lung cancer
- AJCC stage 3 lung cancer
- ECOG performance status 0, 1, or 2
- Follow-up period =1 year after completion of radiotherapy
- The patients who were checked hemoglobin A1c 2 week before the start of radiotherapy
Exclusion Criteria
- Histologically confirmed small cell lung cancer
- Receipt of a total radiotherapy dose =50 Gy
- No available imaging studies for evaluation of cancer recurrence
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method oco-regional recurrence-free survival rate
- Secondary Outcome Measures
Name Time Method Distant metastasis-free survival rate;Overall survival rate